Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Coronary Artery Disease
  • Diabetes Complications
  • Myocardial Infarction
  • Peptide Fragments
  • Stroke

abstract

  • These findings indicate that in diabetic patients, bivalirudin monotherapy results in similar protection from acute ischemic events and long-term mortality, while lowering the risk of minor bleeding in comparison to UFH plus GP IIb/IIIa inhibition.

publication date

  • March 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 20197573

Additional Document Info

start page

  • 94

end page

  • 100

volume

  • 22

number

  • 3